Biosimilar Red Tape Elimination Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 11
- Latest action
- Sep 19, 2025
What it does
The Biosimilar Red Tape Elimination Act would automatically deem biosimilar biological products interchangeable with their reference products upon licensure, eliminating the separate FDA review process currently required for interchangeability.
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Loading recorded actions…
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.